Skip to main content

  • Monday, Aug 23rd
    10:00 AM - 11:30 AM US Eastern Time
    WS-15 - Real World Data in the Era of covid-19: The Devil in the Details. an ISPE RWE Task force/covid-19 Workgroup Symposium
    Location: WS-15
    Disease Epidemiology/Clinical Course
  • Monday, Aug 23rd
    11:45 AM - 1:30 PM US Eastern Time
    OP-4A - Severe Obesity Is a Risk Factor for Mortality in Patients with COVID-19
    Location: OP-04
    Disease Epidemiology/Clinical Course
  • Monday, Aug 23rd
    11:45 AM - 1:30 PM US Eastern Time
    OP-4B - Predictors of Critical Care, Mechanical Ventilation, and Mortality Among Hospitalized Patients with COVID-19 in an Electronic Health Record Database
    Location: OP-04
    Disease Epidemiology/Clinical Course
  • Monday, Aug 23rd
    11:45 AM - 1:30 PM US Eastern Time
    OP-4C - Utilizing the National COVID Cohort Collaborative (N3C) to Evaluate Risk of Serious Outcomes with COVID-19 Among Chronically Immunosuppressed Persons
    Location: OP-04
    Disease Epidemiology/Clinical Course
  • Monday, Aug 23rd
    11:45 AM - 1:30 PM US Eastern Time
    OP-4D - Incidence and Risk Factors for Covid-related Urgent Medical Visits Among US Patients Diagnosed with COVID-19 in the Outpatient Setting
    Location: OP-04
    Disease Epidemiology/Clinical Course
  • Monday, Aug 23rd
    11:45 AM - 1:30 PM US Eastern Time
    OP-4E - Chronic Diseases, Health Conditions and Risk of covid-19-related Hospitalization and In-hospital Mortality During the First Wave of the Epidemic in France: A Cohort Study of 66 Million People
    Location: OP-04
    Disease Epidemiology/Clinical Course
  • Monday, Aug 23rd
    5:30 PM - 6:30 PM US Eastern Time
    L-1A - Use of Remdesivir for COVID-19 in the Real World: An Analysis of US Electronic Medical Records
    Location: L-1
    Disease Epidemiology/Clinical Course
  • Monday, Aug 23rd
    5:30 PM - 6:30 PM US Eastern Time
    L-1B - Comparing Outcomes in Trial-eligible vs Real-world COVID-19 Patients: The Case of Invasive Mechanical Ventilation
    Location: L-1
    Disease Epidemiology/Clinical Course
  • Monday, Aug 23rd
    5:30 PM - 6:30 PM US Eastern Time
    L-1C - Outpatient-identified COVID-19 and Subsequent Hospitalized Thrombotic Events
    Location: L-1
    Disease Epidemiology/Clinical Course
  • Monday, Aug 23rd
    5:30 PM - 6:30 PM US Eastern Time
    L-1D - Patients Tell All: Using a Direct-to-patient Community Registry to Understand Patient Burden of COVID-19
    Location: L-1
    Disease Epidemiology/Clinical Course
  • Monday, Aug 23rd
    6:30 PM - 7:30 PM US Eastern Time
    L-2H - Identification of Serostatus in Rheumatoid Arthritis Using ICD-10 Diagnosis Codes
    Location: L-2
    Disease Epidemiology/Clinical Course
  • Monday, Aug 23rd
    6:30 PM - 7:30 PM US Eastern Time
    L-2N - Prevalence of Myxoid /round Cell Liposarcoma (MRCLS) Among Children and Adults in the United States
    Location: L-2
    Disease Epidemiology/Clinical Course
  • Monday, Aug 23rd
    6:30 PM - 7:30 PM US Eastern Time
    L-2P - Atopic Eczema Associated Fracture Risk and Oral Corticosteroids: A Population-based Cohort Study
    Location: L-2
    Disease Epidemiology/Clinical Course
  • Monday, Aug 23rd
    6:30 PM - 7:30 PM US Eastern Time
    L-2Q - Trends in Sexually Transmitted Infections in the United States Ambulatory Care Clinics from 2005-2016
    Location: L-2
    Disease Epidemiology/Clinical Course
  • Monday, Aug 23rd
    6:30 PM - 7:30 PM US Eastern Time
    L-2R - Chemotherapy Relative Dose Intensity, Overall Survival, and Hematologic Toxicity in Solid-tumor Cancer Patients: A Literature Review and Meta-analysis
    Location: L-2
    Disease Epidemiology/Clinical Course
  • Tuesday, Aug 24th
    1:45 PM - 3:30 PM US Eastern Time
    OP-15F - Comparable COVID-19 Outcomes with Current Use of GLP-1 Receptor Agonists, DPP-4 Inhibitors or SGLT-2 Inhibitors Among Patients with Diabetes Who Tested Positive for sars-cov-2
    Location: OP-15
    Disease Epidemiology/Clinical Course
  • Tuesday, Aug 24th
    1:45 PM - 3:30 PM US Eastern Time
    OP-27F - Development and Validation of an Algorithm to Estimate the Risk of Severe Complications of COVID-19 to Prioritise Vaccination
    Location: OP-27
    Disease Epidemiology/Clinical Course
  • Tuesday, Aug 24th
    3:30 PM - 4:45 PM US Eastern Time
    SP05B - Nonsteroidal Anti-inflammatory Drug Use and Skin Cancer Risk: A Prospective Cohort Study
    Location: SP05
    Disease Epidemiology/Clinical Course
  • Tuesday, Aug 24th
    5:15 PM - 6:30 PM US Eastern Time
    SP09B - Target Blood Pressure Levels and the Risk of Major Adverse Cardiovascular Events Among Patients with Hypertension at Low Cardiovascular Disease Risk
    Location: SP09
    Disease Epidemiology/Clinical Course
  • Tuesday, Aug 24th
    5:15 PM - 6:30 PM US Eastern Time
    SP12H - No Differential Risk of Cutaneous Small Vessel Vasculitis with Oral Anticoagulant Use Among Patients with Atrial Fibrillation
    Location: SP12
    Disease Epidemiology/Clinical Course
  • Tuesday, Aug 24th
    5:15 PM - 6:30 PM US Eastern Time
    SP16D - Burden of Comorbidities Among Adults with Concurrent Obesity and Heart Failure with Preserved Ejection Fraction
    Location: SP16
    Disease Epidemiology/Clinical Course
  • Tuesday, Aug 24th
    5:15 PM - 6:30 PM US Eastern Time
    SP16H - Incidence and Prevalence of Rhabdomyolysis in Patients with Type 2 Diabetes in the US
    Location: SP16
    Disease Epidemiology/Clinical Course
  • Tuesday, Aug 24th
    6:45 PM - 7:45 PM US Eastern Time
    L-3D - Birth Prevalence of Phenylalanine Hydroxylase Deficiency: A Systematic Literature Review and Meta-analysis
    Location: L-3
    Disease Epidemiology/Clinical Course
  • Wednesday, Aug 25th
    10:00 AM - 11:30 AM US Eastern Time
    WS-12 - Pediatric Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV 2) and Potential Health Consequences (submitted on Behalf of the ISPE RWE covid-19 Workgroup)
    Location: WS-12
    Disease Epidemiology/Clinical Course
  • Wednesday, Aug 25th
    11:45 AM - 1:30 PM US Eastern Time
    OP-5D - Persistence of COVID-19 Symptoms 90 Days Post-acute Infection: Insights from a Community-based Registry
    Location: OP-05
    Disease Epidemiology/Clinical Course
  • Wednesday, Aug 25th
    11:45 AM - 1:30 PM US Eastern Time
    OP-7A - Impact of Non-alcoholic Steatohepatitis (NASH) Case Definition on Population Characteristics Identified in a US Claims Database
    Location: OP-07
    Disease Epidemiology/Clinical Course
  • Wednesday, Aug 25th
    11:45 AM - 1:30 PM US Eastern Time
    OP-7B - The Effect of Epidural Steroid Injections on Fracture Risk Among Medicare Patients
    Location: OP-07
    Disease Epidemiology/Clinical Course
  • Wednesday, Aug 25th
    11:45 AM - 1:30 PM US Eastern Time
    OP-7E - Hyperthyroidism and Breast Cancer Recurrence and Mortality: A Danish Population-based Cohort Study
    Location: OP-07
    Disease Epidemiology/Clinical Course
  • Wednesday, Aug 25th
    11:45 AM - 1:30 PM US Eastern Time
    OP-7F - Incidence Rates of Select Outcomes Among Patients with Non-alcoholic Steatohepatitis (NASH) and Evidence of Fibrosis and Cirrhosis
    Location: OP-07
    Disease Epidemiology/Clinical Course
  • Wednesday, Aug 25th
    3:00 PM - 4:30 PM US Eastern Time
    PP-01C - Ethnic Differences in COVID-19 Infection, Hospitalisation, and Mortality: An Opensafely Analysis of 17 Million Adults in England
    Location: PP-01
    Disease Epidemiology/Clinical Course
  • Wednesday, Aug 25th
    3:00 PM - 4:30 PM US Eastern Time
    PP-01E - Multi-depth, Iterative Causal Forest for Subgroup Identification
    Location: PP-01
    Disease Epidemiology/Clinical Course